2,208 followers
Open Access UCL Research: Botulinum toxin type A therapy for blepharospasm https://t.co/GwmytToXOS
292 followers
RT @CochraneUK: Botulinum toxin type A for people with involuntary eyelid closure, or blepharospasm. Updated @CochraneMDG systematic review…
4,929 followers
#ToxinaBotulínica tipo A (TBA) para tratamiento del #Blefarospasmo: #RevisiónSistemática (abro hilo 🧶)
7,381 followers
RT @CochraneUK: Botulinum toxin type A for people with involuntary eyelid closure, or blepharospasm. Updated @CochraneMDG systematic review…
767 followers
RT @CochraneUK: Botulinum toxin type A for people with involuntary eyelid closure, or blepharospasm. Updated @CochraneMDG systematic review…
62,041 followers
Botulinum toxin type A for people with involuntary eyelid closure, or blepharospasm. Updated @CochraneMDG systematic review includes 3 studies with 313 participants: https://t.co/YSr2vUKV0N https://t.co/mInSLqy5Jf
519 followers
RT @CochraneUK: Botulinum toxin type A for people with involuntary eyelid closure, or blepharospasm https://t.co/YSr2vUKV0N Updated @Cochra…
7,381 followers
RT @CochraneUK: Botulinum toxin type A for people with involuntary eyelid closure, or blepharospasm https://t.co/YSr2vUKV0N Updated @Cochra…
767 followers
RT @CochraneUK: Botulinum toxin type A for people with involuntary eyelid closure, or blepharospasm https://t.co/YSr2vUKV0N Updated @Cochra…
62,041 followers
Botulinum toxin type A for people with involuntary eyelid closure, or blepharospasm https://t.co/YSr2vUKV0N Updated @CochraneMDG systematic review includes 3 studies with 313 participants. https://t.co/0rya55RiAS
58 followers
RT @CochraneLibrary: Botulinum toxin type A for people with involuntary eyelid closure, or blepharospasm https://t.co/0PGuELchBT Updated @C…
767 followers
RT @CochraneLibrary: Botulinum toxin type A for people with involuntary eyelid closure, or blepharospasm https://t.co/0PGuELchBT Updated @C…
81,110 followers
Botulinum toxin type A for people with involuntary eyelid closure, or blepharospasm https://t.co/0PGuELchBT Updated @CochraneMDG systematic review includes 3 studies with 313 participants.